Translate
About
Shenzhen Chipscreen Biosciences Co (SHG:688321) — investor relations, events, news, and company updates on 6ix.
Latest News
Dec 30 2025
Dr. Lu Xianping, Founder, Chairman of Chipscreen Biosciences named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards
Jul 31 2025
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development
Financials
Revenue
CN¥909.54 M
Market Cap
CN¥13.3 B
P/E Ratio
250.17
EPS
0.12